96 related articles for article (PubMed ID: 1413044)
1. Liver allograft rejection: analysis of OKT3 rescue therapy.
McCaughan GW; Strasser S; Dolan P; Sheil AG
Transplant Proc; 1992 Oct; 24(5):2250-1. PubMed ID: 1413044
[No Abstract] [Full Text] [Related]
2. FK 506 used as rescue therapy for refractory liver allograft rejection.
Chen CL; Eng HL; Chen YS; Kuo YC; Sun CK
Transplant Proc; 1994 Aug; 26(4):1927-9. PubMed ID: 7520612
[No Abstract] [Full Text] [Related]
3. Early steroid-resistant rejection following orthotopic liver transplantation: new aspects of treatment with FK 506 instead of OKT3?
Dé P; Bechstein WO; Blumhardt G; Lange D; Schattenfroh N; Neuhaus P
Transplant Proc; 1993 Aug; 25(4):2693-4. PubMed ID: 7689279
[No Abstract] [Full Text] [Related]
4. Accelerated liver allograft rejection during prophylactic immunosuppression with OKT3.
Sasaki AW; Lee RG; Porayko MK; Benner KG; Hennell KR; Wheeler LJ; Pinson CW
Transplantation; 1993 Jan; 55(1):216-9. PubMed ID: 8420054
[No Abstract] [Full Text] [Related]
5. Incidence and outcome of OKT3 treatment for early steroid-resistant rejection following hepatic transplantation.
Lange D; Bechstein WO; Blumhardt G; Lemmens P; Schattenfroh N; Neuhaus P
Transplant Proc; 1993 Apr; 25(2):1870-1. PubMed ID: 8470207
[No Abstract] [Full Text] [Related]
6. Induction therapy with OKT3 in pediatric liver-transplant recipients.
Ryckman FC; Schroeder TJ; Pedersen SH; Dittrich VS; Balistreri WF
Transplant Sci; 1994 Dec; 4 Suppl 1():S20-5. PubMed ID: 7627451
[TBL] [Abstract][Full Text] [Related]
7. FK 506 rescue therapy: the rapidity of rejection reversal is related to the subsequent development of CMV disease.
Woodle ES; Perdrizet GA; So S; Jendrisak MD; White HM; Marsh JW
Transplant Proc; 1993 Apr; 25(2):1992-3. PubMed ID: 7682360
[No Abstract] [Full Text] [Related]
8. OKT3/antithymocyte globulin immunoprophylaxis in the prevention of recurrence of acute vanishing bile duct syndrome in retransplanted patients.
Gómez R; Moreno E; Colina F; Gonzalez I; Loinaz C; Garcia I; Luque I; Lumbreras C; Vega V; Moreno C
Transplant Proc; 1994 Dec; 26(6):3701-5. PubMed ID: 7998325
[No Abstract] [Full Text] [Related]
9. Low incidence of chronic rejection in patients experiencing histological acute rejection without simultaneous impairment in liver function tests.
Farges O; Nocci Kalil A; Sebagh M; Reynes M; Bismuth H
Transplant Proc; 1995 Feb; 27(1):1142-3. PubMed ID: 7878827
[No Abstract] [Full Text] [Related]
10. Prognostic value of eosinophils for therapeutic response in severe acute hepatic allograft rejection.
Ben-Ari Z; Dhillon AP; Garwood L; Rolles K; Davidson B; Burroughs AK
Transplant Proc; 1996 Dec; 28(6):3624-8. PubMed ID: 8962399
[No Abstract] [Full Text] [Related]
11. Use of OKT3 for late acute rejection in liver transplantation.
Samuel D; Gugenheim J; Canon C; Saliba F; Bismuth H
Transplant Proc; 1990 Aug; 22(4):1767-8. PubMed ID: 2117804
[No Abstract] [Full Text] [Related]
12. Incidence and patterns of rejection using different induction therapies in liver transplant recipients.
Elkashab M; Reizig M; Greig PD; Cameron R; Phillips MJ; Chung S; Cattral M; Levy G
Transplant Proc; 1994 Oct; 26(5):2669-71. PubMed ID: 7940835
[No Abstract] [Full Text] [Related]
13. Treatment of steroid-resistant rejection with tacrolimus prior to OKT3 in liver transplant recipients.
Millis JM; Bruce DS; Newell KA; Piper JB; Woodle ES; Seaman DS; Baker AL; Hart J; Dasgupta K; Thistlethwaite JR
Transplant Proc; 1996 Apr; 28(2):1014. PubMed ID: 8623213
[No Abstract] [Full Text] [Related]
14. OKT3 vs FK 506 rescue management of acute steroid-resistant and chronic rejection.
Platz KP; Mueller AR; Zytowski M; Bechstein WO; Blumhardt G; Lobeck H; Neuhaus P
Transplant Proc; 1995 Feb; 27(1):1111-3. PubMed ID: 7533357
[No Abstract] [Full Text] [Related]
15. OKT3 treatment of cardiac allograft rejection.
Haverty TP; Sanders M; Sheahan M
J Heart Lung Transplant; 1993; 12(4):591-8. PubMed ID: 8369321
[TBL] [Abstract][Full Text] [Related]
16. Clinical and immunological aspects of liver allograft rejection.
Schlitt HJ
Transplant Proc; 1996 Feb; 28(1):514-6. PubMed ID: 8644333
[No Abstract] [Full Text] [Related]
17. FK 506 rescue therapy for hepatic allograft rejection: experience with an aggressive approach.
Woodle ES; Perdrizet GA; So SK; White HM; Marsh JW
Clin Transplant; 1995 Feb; 9(1):45-52. PubMed ID: 7537988
[TBL] [Abstract][Full Text] [Related]
18. Consequences of anti-OKT3 antibody development: OKT3 reuse and long-term graft survival.
Shield CF
Transplant Proc; 1993 Apr; 25(2 Suppl 1):81-2. PubMed ID: 8465434
[No Abstract] [Full Text] [Related]
19. Posttransplant lymphoproliferative disorders in liver recipients treated with OKT3 or ALG induction immunosuppression.
McAlister V; Grant D; Roy A; Yilmaz Z; Ghent C; Wall W
Transplant Proc; 1993 Feb; 25(1 Pt 2):1400-1. PubMed ID: 8442154
[No Abstract] [Full Text] [Related]
20. Liver transplantation from cadaveric and living donors.
Lo CM; Lo RJ; Lai CL; Fan ST; Wong J
Transplant Proc; 1996 Jun; 28(3):1659-60. PubMed ID: 8658826
[No Abstract] [Full Text] [Related]
[Next] [New Search]
